VOMIFOLYL-6-O-BETA-D-XYLOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
Compound with spectra: 2 NMR
| SpectraBase Compound ID | K2OazJb31di |
|---|---|
| InChI | InChI=1S/C24H38O12/c1-11-7-13(25)8-23(3,4)24(11,32)6-5-12(2)35-22-20(31)18(29)17(28)15(36-22)10-34-21-19(30)16(27)14(26)9-33-21/h5-7,12,14-22,26-32H,8-10H2,1-4H3/b6-5+/t12?,14-,15-,16+,17-,18+,19-,20-,21+,22-,24?/m1/s1 |
| InChIKey | ZHAMWJWQXSZIAQ-NGIXXOOGSA-N |
| Mol Weight | 518.6 g/mol |
| Molecular Formula | C24H38O12 |
| Exact Mass | 518.236327 g/mol |
| Enantiomer InChIKey | ZHAMWJWQXSZIAQ-ZRQBEAGBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
- VOMIFOLIOL_1-O-BETA-D-XYLOPYRANOSYL-6-O-BETA-D-GLUCOPYRANOSIDE;4-(1-HYDROXY-4-KETO-2,6,6-TRIMETHYLCYCLOHEX-2-EN-1-YL)-BUT-3-EN-2-YL_1-O-BETA-D-YXLO
(6S,7E,9R)-6,9-DIHYDROXY-4,7-MEGASTIGMADIEN-3-ONE-9-O-[ALPHA-L-ARABINOFURANOSYL-(1->6)]-BETA-D-GLUCOPYRANOSIDE
(9R)-2-BETA,9-DIHYDROXYMEGASTIGMA-4,7-DIEN-3-ONE-9-O-ALPHA-L-RHAMNOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
SAUROPOSIDE
TRICALYSIONOSIDE-A;(9S)-ICARISIDE-B5-6'-O-BETA-D-GLUCOPYRANOSIDE
ALANGIONOSIDE-B
(6S,9S)-6,9-DIHYDROXYMEGASTIMAN-4-EN-9-O-BETA-D-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
GLOCHIDIONIONOSIDE-A;(6S,7E,9S)-MEGASTIGMAN-3-ONE-4,7-DIEN-6,9,13-TRIOL-13-O-BETA-D-GLUCOPYRANOSIDE
SACHALOSIDE-II
| Title | Journal or Book | Year |
|---|---|---|
| Linalyl and bornyl disaccharide glycosides from Gardenia jasminoides flowers | Phytochemistry | 1994 |
| Vomifoliol 1-O-β-d-xylopyranosyl-6-O-β-d- glucopyranoside: A disaccharide glycoside from apple fruit | Phytochemistry | 1990 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.